Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Cell & Gene Therapy Supply Chain Software Market Expected to Grow at a 13.9% CAGR from 2024-2031 | Latest Report by InsightAce Analytic

      InsightAce Analytic Pvt. Ltd Logo

      News provided by

      InsightAce Analytic Pvt. Ltd

      Jun 10, 2024, 10:15 ET

      Share this article

      Share this article


      JERSEY CITY, N.J., June 10, 2024 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell & Gene Therapy Supply Chain Software Market Size, Share & Trends Analysis Report By Business Type (Transport, Warehouse, Distribution, Value-Added Services), Mode Of Operation (Storage, Roadways, Seaways), And End Use, Region, Market Outlook And Industry Analysis 2031".

      The Cell & Gene Therapy Supply Chain Software Market is poised for significant growth, projected to surpass USD 668.4 Mn by 2031, with a promising CAGR of 13.9% during the forecast period.

      Enhanced therapies, including cell and gene therapy products, have reformed healthcare practices. The prevalence of such therapeutic options has led to an uprise shift in modern medicine's development, production, and consumption. Moreover, such therapies have established healthcare providers to treat several rare clinical conditions.

      Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/2520 

      Supply chain software in this sector encompasses solutions for inventory management, logistics, temperature monitoring, and regulatory compliance. It facilitates the coordination of multiple stakeholders, including manufacturers, contract research organizations (CROs), logistics providers, and healthcare facilities. Investments in R&D are also essential for advancing technological innovations and raising the caliber of produced goods.

      Furthermore, the market's future potential appears bright because of the growing use of digitalization. Various software solutions play crucial roles in these processes, including cell rearrangement platforms, Enterprise-manufacturing systems, inventory management systems, laboratory information management systems, logistics management systems, patient management systems, quality management systems, and tracking and tracing systems.

      List of Prominent Key Players in the Cell and Gene Therapy Supply Chain Software Market:

      • Azenta Life Sciences
      • Biocair
      • BioLife Solutions
      • CareDx
      • Cryoport
      • Lonza
      • NMDP BioTherapies
      • TraceLink
      • TrakCel
      • Veeva Systems
      • Emerson
      • LabVantage Solutions
      • Marken
      • MasterControl
      • QuickSTAT
      • Siemens
      • Stafa Cellular Therapy
      • Steiner
      • STEMSOFT Software
      • TECHNICAL
      • Thermo Fisher Scientific
      • Other Prominent Players

      Cell and Gene Therapy Supply Chain Software Market Scope:

      Report Attribute

      Specifications

      Market Size Value In 2023

      USD 240.5 Mn

      Revenue Forecast In 2031

      USD 668.4 Mn

      Growth Rate CAGR

      CAGR of 13.9% from 2024 to 2031

      Quantitative Units

      Representation of revenue in US$ Mn, and CAGR from 2024 to 2031

      Historic Year

      2019 to 2023

      Forecast Year

      2024-2031

      Report Coverage

      The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

      Segments Covered

      By Process Component, Type of Software, Mode of Deployment, Type of End-User, And Scale of Operation

      Regional Scope

      North America; Europe; Asia Pacific; Latin America; Middle East & Africa

      Country Scope

      U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea

      Order 180 Pages Full Report @  https://www.insightaceanalytic.com/buy-report/2520 

      Market Dynamics:

      Drivers-

      Several key factors drive the Cell and Gene Therapy Supply Chain Software Market. Primarily, the rising demand for personalized medicine and advanced therapies fuels the need for efficient supply chain management solutions. Also, the complexity of cell and gene therapy manufacturing requires sophisticated software to ensure product quality and compliance with regulatory standards. In addition, the rising number of clinical trials and commercial launches of these therapies boosts demand for software that can accommodate the unique challenges of their supply chains. Lastly, the COVID-19 pandemic has underscored the importance of resilient supply chains, driving further interest in software solutions to enhance agility and visibility.

      Challenges:

      The Cell & Gene Therapy Supply Chain Software Market faces several challenges. The high cost of developing and implementing specialized software poses a barrier to entry for smaller companies. Also, regulatory complexities and stringent compliance requirements add layers of difficulty to software development and usage. Interoperability issues between different systems can hinder seamless data exchange and integration. Lastly, the need for continuous adaptation to evolving technologies and industry standards presents ongoing challenges for software providers and users alike, requiring constant updates and enhancements to meet the dynamic needs of the cell and gene therapy sector.

      Regional Trends:

      North America is a leading region in the biotechnology and pharmaceutical industries, boasting a robust ecosystem of companies specializing in cell and gene therapy research, development, and manufacturing. The region's leading software companies and technology hubs further enhance its position. This comprehensive overview of regional trends is crucial for regulatory authorities to stay informed and make informed decisions.

      Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2520 

      Recent Developments:

      • In January 2024, Veeva Systems partnered with SK Biopharmaceuticals to optimize the former company's quality management system and decrease the risks involved with quality assurance of regenerative healthcare medicine.
      • In Nov 2023, Cryoport, Inc. announced its acquisition of Tec4med LifeScience GmbH. Cryoport's acquire of Tec4med is a significant step in broadening their range of condition monitoring solutions, fostering new product development, and accelerating European market penetration, notably in the DACH area (Germany, Austria, Switzerland).
      • In June 2023, Biocair has integrated TrakCel's software with OCELLOS to increase customer service, automation, and visibility in the cell and gene therapy (CGT) supply chain.TrakCel's advanced therapeutic orchestration platform OCELLOS streamlines the cell, gene, and immunotherapy supply chain. To scale cell and gene therapy development, the platform tracks chain of identification and custody. This lets stakeholders track orders in transit.

      Segments of Cell and Gene Therapy Supply Chain Software Market -

      By Process Component-              

      • Sample Collection and Processing Component
      • Manufacturing Component
      • Logistics Component
      • Patient Identification and Treatment Follow-up Component

      By Type of Software-    

      • Enterprise Manufacturing System (EMS)
      • Laboratory Information Management System (LIMS)
      • Inventory Management System (IMS)
      • Cell Orchestration Platform (COP)
      • Quality Management System (QMS)
      • Logistics Management System (LMS)
      • Patient Management System (PMS)

      By Mode of Deployment-           

      • On-premises Deployment
      • Cloud-based Deployment

      By Type of End-User-    

      • Pharmaceutical Companies
      • Cell Therapy Labs
      • Hospitals / Medical Centers
      • Research Institutes / Biobanks

      By Scale of Operation- 

      • Clinical Scale
      • Commercial Scale

      By Region-

      North America-

      • The US
      • Canada
      • Mexico

      Europe-

      • Germany
      • The UK
      • France
      • Italy
      • Spain
      • Rest of Europe

      Asia-Pacific-

      • China
      • Japan
      • India
      • South Korea
      • Southeast Asia
      • Rest of Asia Pacific

      Latin America-

      • Brazil
      • Argentina
      • Rest of Latin America

       Middle East & Africa-

      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa

      For More Customization @ https://www.insightaceanalytic.com/customisation/2520 

      Why should buy this report:

      • To receive a comprehensive analysis of the prospects for global Cell and Gene Therapy Supply Chain Software market
      • To receive industry overview and future trends of global Cell and Gene Therapy Supply Chain Software market
      • To analyze the Cell and Gene Therapy Supply Chain Software market drivers and challenges
      • To get information on the Cell and Gene Therapy Supply Chain Software market size value (US$ Mn) forecast till 2031
      • Major Investments, Mergers & Acquisition in global Cell and Gene Therapy Supply Chain Software industry

      Other Related Reports Published by InsightAce Analytic:

      AI in Patient Management Market 

      Digital Pharmaceutical Supply Chain Management Market 

      4PL Logistics Market

      AI in Medical Supplies/Inventory Management Market

      Patient Engagement Solutions Market

      About Us:

      InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

      Contact Us:
      InsightAce Analytic PVT. LTD
      Tel.: +1 551 226 6109
      Email: [email protected]
      Follow us on LinkedIn: https://www.linkedin.com/company/insightace-analytic-pvt-ltd/

      Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg

      SOURCE InsightAce Analytic Pvt. Ltd

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.